TCL Archive Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says. By Cancer History Project May 20, 2005
TCL Archive Onward to 2010? NCI promises faster progress for more money. By Cancer History Project May 20, 2005
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. By Cancer History Project May 13, 2005
TCL Archive University of Pittsburgh honors breast cancer surgeon and clinical trialist Bernard Fisher with lecture and portrait. By Cancer History Project May 13, 2005
TCL Archive NIH oncology peer reviewers are protesting the outcome of a recent meeting in which their own grant applications fared so poorly that the reviewers said they were penalized for their service. By Cancer History Project May 6, 2005
TCL Archive Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds. By Cancer History Project May 6, 2005
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. By Cancer History Project May 6, 2005
TCL Archive Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting. By Cancer History Project April 29, 2005
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
